Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Cidara Therapeutics Inc

Start price
Target price
Perf. (%)
€1.43
06.02.23
€3.00
31.12.25
-35.87%
05.05.23

Could be very worthwhile Investment >20% year
buy
Larimar Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.18
20.09.22
€7.00
31.08.25
32.08%
05.05.23

Could be very worthwhile Investment >20% year
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€2.16
10.01.23
€4.00
31.12.25
-46.57%
05.05.23

Could be very worthwhile Investment >20% year
buy
First Wave BioPharma Inc.

Start price
Target price
Perf. (%)
€5.11
14.01.23
€14.00
28.02.25
-12.33%
05.05.23

Could be very worthwhile Investment >20% year
buy
PDS Biotechnology Corp.

Start price
Target price
Perf. (%)
€12.03
24.12.22
€13.00
31.12.25
-53.28%
05.05.23

Could be very worthwhile Investment >20% year
buy
TRACON Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€3.20
24.12.22
€5.00
31.05.25
-
05.05.23

Could be very worthwhile Investment >20% year
buy
IVERIC bio Inc.

Start price
Target price
Perf. (%)
€17.23
29.09.22
€26.00
31.12.24
98.47%
05.05.23

Could be very worthwhile Investment >20% year
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€9.62
24.04.23
-
24.04.24
-1.47%
29.04.23

Risky Investment
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€4.05
09.01.23
-
20.04.26
161.40%
28.04.23

Could be worthwhile Investment >10% per year
Very high cyclical dependencies
BELLUS Health Inc.

Start price
Target price
Perf. (%)
€13.20
18.04.23
-
18.04.24
-1.52%
27.04.23

Growths slower than the competition
Higher risks for its business
buy
iBio Inc.

Start price
Target price
Perf. (%)
€1.18
27.02.23
€1.10
27.02.24
-16.47%
26.04.23

Capable Management
Good culture
Valuable balance sheet
Dependend from some customers or products
Newron Pharmaceut.

Start price
Target price
Perf. (%)
€7.58
21.02.23
-
21.02.24
-37.99%
24.04.23

Probably not worthwhile Investment
Cidara Therapeutics Inc

Start price
Target price
Perf. (%)
€1.57
07.03.23
-
07.03.24
-37.32%
24.04.23

Probably not worthwhile Investment
Vaxart Inc.

Start price
Target price
Perf. (%)
€1.05
22.01.23
-
22.01.24
-38.99%
24.04.23

Probably not worthwhile Investment
Spineway

Start price
Target price
Perf. (%)
€2.20
12.12.22
-
12.12.23
-61.36%
24.04.23

Risky Investment
Growths slower than the competition
Check Cap Ltd

Start price
Target price
Perf. (%)
€1.89
27.12.22
-
27.12.23
-32.12%
24.04.23

Risky Investment
CytoTools AG

Start price
Target price
Perf. (%)
€1.15
28.11.22
-
28.11.23
91.30%
24.04.23

Probably not worthwhile Investment
Novacyt S.A.

Start price
Target price
Perf. (%)
€1.06
05.09.22
-
05.09.23
-46.97%
24.04.23

Probably not worthwhile Investment
Neurosearch As Nam.

Start price
Target price
Perf. (%)
€27.00
03.10.22
-
03.10.23
87.41%
24.04.23

Probably not worthwhile Investment
Inotiv Inc.

Start price
Target price
Perf. (%)
€13.40
01.05.22
-
01.05.23
-63.13%
24.04.23

Probably not worthwhile Investment
buy
iBio Inc.

Start price
Target price
Perf. (%)
€1.55
06.03.23
€3.00
06.03.24
-38.59%
16.04.23

Some uniques
Significant cyclical dependencies
Little known brand
Higher risks for its business
Inotiv Inc.

Start price
Target price
Perf. (%)
€3.96
01.04.23
€2.00
01.04.24
10.10%
15.04.23

Probably not worthwhile Investment
Below average Management
Bad culture
buy
Cidara Therapeutics Inc

Start price
Target price
Perf. (%)
€1.08
25.01.23
-
25.01.24
-9.02%
14.04.23

Risky Investment
buy
Gensight Biologics SA

Start price
Target price
Perf. (%)
€2.34
07.04.22
-
07.04.23
-1.02%
08.04.23

Could be worthwhile Investment >10% per year
buy
Cellectis SA ADR

Start price
Target price
Perf. (%)
€4.20
03.04.22
-
03.04.23
-58.10%
04.04.23

Could be worthwhile Investment >10% per year